Light Horse

KSQ Therapeutics

The company develops gene-edited cell therapies and small molecule medicines for oncology patients and pharmaceutical partners using a functional genomics discovery platform.

CHARM Therapeutics

This company develops small-molecule drugs for cancer patients using a deep-learning platform that models protein-ligand interactions to identify novel therapeutic targets.

THERAtRAME

The company develops small molecule inhibitors targeting tRNA epitranscriptomics to treat resistant and immune-refractory cancers for patients with limited therapeutic options.

Eikon Therapeutics

This biopharmaceutical company develops small molecule medicines for patients with cancer and other serious diseases using a live-cell imaging drug discovery platform.

Auron Therapeutics

This company develops small-molecule drugs using an AI-powered platform to treat patients with cancer and inflammatory diseases.

Chromacure

This company develops small molecule therapeutics for oncology patients to address unmet clinical needs in cancer treatment.

Alterome Therapeutics

This company develops small-molecule targeted therapies for cancer patients by using computational chemistry to address specific genetic mutations.

Accent Therapeutics

This biopharmaceutical company develops small molecule precision therapies for patients with various types of cancer.